Steve Basta has been our Chief Executive Officer since November 2002, also serving as President from November 2002 to June 2007. From December 2000 to November 2002, he was President, and later Chief Executive Officer, of Gliatech Inc., a publicly-traded medical device and drug discovery company. Prior to joining Gliatech Inc., Mr. Basta was Vice President, Business Development of Creative BioMolecules Inc. from 1997 to 2000, and served as its Chief Financial Officer from 1999 to 2000. Mr. Basta holds a B.A. from The Johns Hopkins University and a Masters in Management from the Kellogg Graduate School of Management at Northwestern University.
Derek Bertocci has been our Chief Financial Officer since October 2006 and our Secretary since July 2007. From June 2005 to July 2006, he was Chief Financial Officer of Laserscope, a publicly-traded provider of lasers and fiber optic devices for urology and aesthetic surgery. From March 2004 to May 2005, Mr. Bertocci served as Chief Financial Officer of VISX Incorporated, a publicly-traded laser vision correction company. From 1998 to March 2004, Mr. Bertocci served as Vice President and Controller of VISX. Mr. Bertocci earned his Certified Public Accountant (CPA) certification while working for PricewaterhouseCoopers. Mr. Bertocci holds a B.A. from Stanford University and an M.B.A. from the University of Southern California.
Dennis Condon has been our President and Chief Business Officer since June 2007 and served as a member of our board of directors from January 2004 to June 2007. From March 2006 to June 2007, he was the Chief Executive Officer and President of Apsara Medical, a medical device company focused on the aesthetics market. From February 2005 to November 2005, Mr. Condon was the President and Chief Executive Officer of Reliant Technologies Inc., a provider of lasers for aesthetic applications. Since November 2002, Mr. Condon has also served as a principal of a privately-held medical aesthetics services practice. From 1998 to July 2002, he was Chief Executive Officer of The Plastic Surgery Company, a healthcare services company. From 1991 to 1998, he was President of Mentor Corporation’s aesthetics division. Mr. Condon holds a B.S. from the University of California, Davis.
Jaap de Lange has been the Managing Director of BioForm Medical Europe B.V. since March 2004, also serving as our Vice President since October 2005. From October 2003 to March 2004, Mr. de Lange served as our Director of European Sales. From 2000 to October 2003, Mr. de Lange served as the President of Optis B.V., an international consulting firm focused on sales and marketing and business development services. Mr. de Lange holds a B.S. from a university in the Netherlands.
Dale DeVore, Ph.D. has been our Vice President, Research and Development since October 2004. Since 2001, Dr. DeVore has also been an independent consultant to the medical device/tissue engineering industry. Dr. DeVore holds a B.S., an M.S., and a Ph.D. from Rutgers University.
Dean Erickson has been our Vice President, Manufacturing and General Manager of Wisconsin Operations since October 2003. From January 2003 to October 2003, he was our Director of Manufacturing and from 2000 to December 2002, he was our Technical Operations Manager. Mr. Erickson holds a B.S. from the University of Wisconsin, Milwaukee.
Adam Gridley has been our Vice President, Corporate Development since July 2005. From April 2004 to July 2005, he was our Director of Corporate Development and from September 2003 to April 2004, he was our Director of Market Development. From 1996 to June 2003, he was with Gliatech Inc., where he most recently was Director of Business Development. Mr. Gridley holds a B.S. and an M.B.A. from the University of Denver.
Chris Holmes has been our Vice President, Sales since May 2006. From 1998 to May 2006, he was the Vice President of Sales for Skinceuticals LLC., a dermatology company. Mr. Holmes holds a B.S. from Montgomery College.
Sylvia Kamenski has been our Vice President, Controller since May 2007. From June 2004 through May 2007, Ms. Kamenski worked at Southwall Technologies Inc., a publicly-traded developer of coating technologies for windows, where, from June 2005 through May 2007, she served as acting Chief Financial Officer and as Vice President of Finance, and where, from June 2004 through June 2005, she served as Controller. From September 2003 to June 2004, she was Financial Reporting Manager at NPtest Holding, a publicly-traded semiconductor equipment manufacturer. From 2001 to August 2003, Ms. Kamenski was Controller at Genus Inc., a publicly-traded semiconductor equipment manufacturer. Ms. Kamenski earned her Certified Public Accountant (CPA) certification while working for PricewaterhouseCoopers. Ms. Kamenski holds a B.S. from the University of San Francisco.
Jim Miller has been our Vice President, Regulatory Affairs and Quality Assurance since July 2003, and had management responsibilities for Clinical Affairs from July 2003 to January 2005. From 1999 to July 2003, Mr. Miller held the position of Vice President, Clinical and Regulatory Affairs and Quality Assurance for Transurgical Inc., a cardiovascular device company. Mr. Miller holds a B.S. from Wagner College.
Lisa Norcia has been our Vice President, Clinical Affairs since October 2005. From May 2003 to October 2005, Ms. Norcia was our Director of Clinical Affairs. From April 2002 to May 2003, she was Director of Ticket Operations for the Staten Island Yankees, a minor league baseball team. From January 1996 to April 2002, Ms. Norcia was Director of Clinical Affairs at Datascope Corporation, a cardiovascular device company. Ms. Norcia holds a B.A. from the University of California at Berkeley and a Master of Public Health from Boston University.
Freddie Park has been our Vice President, Intellectual Property since April 2007. From February 2006 through March 2007, Ms. Park was Vice President of Intellectual Property at Connetics Corporation Inc., a publicly-traded pharmaceutical company. From May 2005 to February 2006, she was Vice President and Chief Intellectual Property Counsel at Advanced Medical Optics, a publicly-traded ophthalmology company, and from 1998 to May 2005, she was Director of Intellectual Property at VISX Inc. Ms. Park holds a B.S. from Texas Tech University and a J.D. from George Mason University School of Law.
Brian Pilcher, Ph.D. has been our Vice President, Medical Affairs & Clinical Education since October 2007. From January 2006 to October 2007, Dr. Pilcher was our Director of Clinical Education and from December 2004 to December 2005 he was our Medical Science Liaison. From 2001 to November 2004, he was with Cutanix Corporation, a privately held specialty pharmaceuticals company, where he most recently served as Director of Research. From January 2002 to December 2004, he was the Adjunct Assistant Professor, Department of Cell Biology, at The University of Oklahoma Health Sciences Center. Dr. Pilcher holds a B.S. from Southern Nazarene University and a Ph.D. from The University of Oklahoma.
Jason Shelton has been our Vice President, Marketing since September 2005. From 2000 to September 2005, he was with Align Technology Inc., a publicly-traded orthodontics company, where he most recently served as the Senior Director of Marketing. Mr. Shelton holds a B.S. from Ohio State University and an M.B.A. from the Katz Graduate School of Business at the University of Pittsburgh.